- Home
- SPAI vs MIST Comparison
SPAI vs MIST Comparison
Compare SPAI & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPAI
- MIST
- Stock Information
- Founded
- SPAI 2021
- MIST 2003
- Country
- SPAI United States
- MIST Canada
- Employees
- SPAI N/A
- MIST N/A
- Industry
- SPAI Industrial Specialties
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- SPAI Health Care
- MIST Health Care
- Exchange
- SPAI Nasdaq
- MIST Nasdaq
- Market Cap
- SPAI 139.4M
- MIST 163.2M
- IPO Year
- SPAI 2024
- MIST N/A
- Fundamental
- Price
- SPAI $4.31
- MIST $2.32
- Analyst Decision
- SPAI Strong Buy
- MIST Strong Buy
- Analyst Count
- SPAI 3
- MIST 3
- Target Price
- SPAI $10.00
- MIST $6.33
- AVG Volume (30 Days)
- SPAI 258.2K
- MIST 2.3M
- Earning Date
- SPAI 11-14-2025
- MIST 11-12-2025
- Dividend Yield
- SPAI N/A
- MIST N/A
- EPS Growth
- SPAI N/A
- MIST N/A
- EPS
- SPAI N/A
- MIST N/A
- Revenue
- SPAI $1,266,756.00
- MIST N/A
- Revenue This Year
- SPAI N/A
- MIST N/A
- Revenue Next Year
- SPAI $538.54
- MIST N/A
- P/E Ratio
- SPAI N/A
- MIST N/A
- Revenue Growth
- SPAI N/A
- MIST N/A
- 52 Week Low
- SPAI $1.47
- MIST $0.63
- 52 Week High
- SPAI $9.16
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- SPAI 34.12
- MIST 67.09
- Support Level
- SPAI $4.15
- MIST $1.85
- Resistance Level
- SPAI $5.13
- MIST $2.50
- Average True Range (ATR)
- SPAI 0.49
- MIST 0.15
- MACD
- SPAI -0.10
- MIST 0.06
- Stochastic Oscillator
- SPAI 5.81
- MIST 78.24
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).